MiR-136 also inhibits cell survival, proliferation, cancer stem cell spheroid formation, and tumor angiogenesis in paclitaxel-resistant ovarian cancer cells by targeting Notch3 [37]. This evidence concerns the gene NOTCH3 and ovarian carcinoma.